drugset / Trial / NCT01766466
Cangrelor Ticagrelor Transition Study
RandomizedFactorialOpen-label
Summary
To demonstrate that patients treated with cangrelor can be directly switched to oral ticagrelor and that patients treated with ticagrelor can be switched to cangrelor without a significant decrease in the extent of inhibition of platelet aggregation.
Timeline
- Start
- 2013-01
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cangrelor | Small molecule | 4 ug/kg | Intravenous |
| Subject | Ticagrelor | Small molecule | 90 mg | Oral |
| Subject | Ticagrelor | Small molecule | 180 mg | Oral |